ASCEND BY NTHRYS
Research Abroad Products

Pharmacogenetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 121–132 of 200 project topics
Real-time CYP450 Genotype Interpretation SaaS Platform
A cloud-based platform that rapidly processes patient CYP450 genetic data and generates actionable drug metabolism phenotypes for clinical decision-making. This enables pharmaceutical companies and healthcare providers to offer personalized dosing recommendations, reducing adverse events and improving patient outcomes.
Cardiovascular Pharmacogenetics Platform Dev Click to view more details →
Warfarin INR Response Prediction Engine and Dosing Tool
A proprietary algorithm combining CYP2C9 and VKORC1 genotyping with clinical variables to predict individual warfarin dosing requirements and INR stability. This tool reduces time-to-therapeutic INR, decreases bleeding complications, and creates recurring revenue through licensing to anticoagulation clinics and hospital systems.
Cardiovascular Pharmacogenetics Platform Dev Click to view more details →
Statin Efficacy and Toxicity Risk Stratification Platform
A diagnostic platform utilizing SLCO1B1 and other relevant polymorphisms to predict statin metabolism, muscle toxicity risk, and lipid-lowering response for individual patients. This enables cardiologists and primary care networks to optimize statin selection and dosing, improving patient adherence and generating per-test revenue.
Cardiovascular Pharmacogenetics Platform Dev Click to view more details →
ACE Inhibitor and ARB Response Biomarker Discovery Platform
A machine learning-driven platform that identifies genetic variants and biomarker signatures predicting ACE inhibitor and ARB efficacy in hypertension and heart failure populations. This supports pharmaceutical companies in stratifying patient populations for clinical trials and enables precision medicine applications that improve therapeutic success rates.
Cardiovascular Pharmacogenetics Platform Dev Click to view more details →
Beta-Blocker Metabolism and Heart Rate Response Prediction
An integrated SaaS solution analyzing CYP2D6 variants and sympathetic nervous system polymorphisms to forecast beta-blocker efficacy and target heart rate achievement in individual patients. This drives adoption among cardiology practices through improved blood pressure control outcomes and potential reimbursement through outcome-based pricing models.
Cardiovascular Pharmacogenetics Platform Dev Click to view more details →
Clopidogrel and Antiplatelet Drug Activation Genomic Analyzer
A rapid diagnostic tool that genotypes CYP2C19 and other relevant variants to predict clopidogrel prodrug activation and personalized antiplatelet therapy selection for acute coronary syndrome patients. This supports interventional cardiology centers in reducing stent thrombosis events and creates revenue through laboratory partnerships and hospital system licensing agreements.
Cardiovascular Pharmacogenetics Platform Dev Click to view more details →
Digoxin Toxicity Risk and Narrow Therapeutic Index Monitoring
A specialized pharmacogenomic platform combining P-glycoprotein transporter variants and renal function assessment to predict digoxin accumulation and arrhythmia risk in heart failure patients. This provides clinical value to geriatric cardiology practices and generates recurring subscription revenue through continuous patient monitoring dashboards.
Cardiovascular Pharmacogenetics Platform Dev Click to view more details →
Cardiovascular Polypharmacy Drug-Drug Interaction Intelligence Engine
An AI-powered clinical decision support tool that uses pharmacogenomic data to identify high-risk drug interactions between antiarrhythmic agents, beta-blockers, statins, and anticoagulants in complex patients. This reduces hospitalizations from adverse drug interactions and monetizes through EHR integrations and pharmaceutical consulting services for medication therapy management programs.
Cardiovascular Pharmacogenetics Platform Dev Click to view more details →
Hypertension Precision Medicine Phenotyping and Drug Matching Platform
A comprehensive genomic profiling and clinical decision support platform that matches individual hypertensive patients to optimal first-line antihypertensive agents based on genetic and biomarker profiles. This enables healthcare systems to reduce uncontrolled hypertension rates and creates B2B SaaS revenue through tiered subscription models and outcome-based incentives.
Cardiovascular Pharmacogenetics Platform Dev Click to view more details →
Heart Failure Medication Optimization and Prognosis Prediction Tool
A patient-stratification platform integrating pharmacogenomic variants with biomarkers to optimize beta-blocker, ACE inhibitor, and aldosterone antagonist selection and predict medication response in heart failure patients. This supports heart failure clinics in improving ejection fraction recovery rates and revenue-shares with hospitals through improved quality metrics and reduced readmissions.
Cardiovascular Pharmacogenetics Platform Dev Click to view more details →
Real-time CYP450 Phenotype Prediction Engine Platform
A SaaS platform that analyzes patient genetic variants to predict cytochrome P450 metabolizer status and generate instant dosing recommendations for opioids and NSAIDs. Pharmacies and hospitals monetize through per-test licensing while reducing adverse drug events and improving patient outcomes by 35-40%.
Pain Management Pharmacogenetics Analytics Click to view more details →
Opioid Response Genotyping Analytics Dashboard
A cloud-based clinical analytics tool that integrates pharmacogenomic data with patient EHR systems to identify optimal opioid medications and doses based on individual genetic profiles. Providers reduce opioid-related complications by 45% and increase patient satisfaction scores, creating recurring SaaS revenue of $50K-200K annually per health system.
Pain Management Pharmacogenetics Analytics Click to view more details →